213 related articles for article (PubMed ID: 31138602)
41. Focal Adhesion Kinase (FAK) tyrosine 397E mutation restores the vascular leakage defect in endothelium-specific FAK-kinase dead mice.
Alexopoulou AN; Lees DM; Bodrug N; Lechertier T; Fernandez I; D'Amico G; Dukinfield M; Batista S; Tavora B; Serrels B; Hodivala-Dilke K
J Pathol; 2017 Jul; 242(3):358-370. PubMed ID: 28444899
[TBL] [Abstract][Full Text] [Related]
42. E17K substitution in AKT1 in prostate cancer.
Boormans JL; Korsten H; Ziel-van der Made AC; van Leenders GJ; Verhagen PC; Trapman J
Br J Cancer; 2010 May; 102(10):1491-4. PubMed ID: 20407443
[TBL] [Abstract][Full Text] [Related]
43. A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
Kurenova E; Ucar D; Liao J; Yemma M; Gogate P; Bshara W; Sunar U; Seshadri M; Hochwald SN; Cance WG
Cell Cycle; 2014; 13(16):2542-53. PubMed ID: 25486195
[TBL] [Abstract][Full Text] [Related]
44. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
Yousif NG
Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
[TBL] [Abstract][Full Text] [Related]
45. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
46. The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas.
Shoji K; Oda K; Nakagawa S; Hosokawa S; Nagae G; Uehara Y; Sone K; Miyamoto Y; Hiraike H; Hiraike-Wada O; Nei T; Kawana K; Kuramoto H; Aburatani H; Yano T; Taketani Y
Br J Cancer; 2009 Jul; 101(1):145-8. PubMed ID: 19491896
[TBL] [Abstract][Full Text] [Related]
47. FAK regulates E-cadherin expression via p-SrcY416/p-ERK1/2/p-Stat3Y705 and PPARγ/miR-125b/Stat3 signaling pathway in B16F10 melanoma cells.
Pei G; Lan Y; Chen D; Ji L; Hua ZC
Oncotarget; 2017 Feb; 8(8):13898-13908. PubMed ID: 28108732
[TBL] [Abstract][Full Text] [Related]
48. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
Hehlgans S; Eke I; Cordes N
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
[TBL] [Abstract][Full Text] [Related]
49. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
Zhang W; Tang B; Huang Q; Hua Z
J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
[TBL] [Abstract][Full Text] [Related]
50. Protein kinase B/AKT and focal adhesion kinase: two close signaling partners in cancer.
Wang S; Basson MD
Anticancer Agents Med Chem; 2011 Dec; 11(10):993-1002. PubMed ID: 22023045
[TBL] [Abstract][Full Text] [Related]
51. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.
Watson KL; Moorehead RA
BMC Cancer; 2013 Aug; 13():375. PubMed ID: 23919516
[TBL] [Abstract][Full Text] [Related]
52. Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts.
Geletu M; Adan H; Niit M; Arulanandam R; Carefoot E; Hoskin V; Sina D; Elliott B; Gunning P; Raptis L
Exp Cell Res; 2021 Jul; 404(1):112601. PubMed ID: 33957118
[TBL] [Abstract][Full Text] [Related]
53. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells.
Lee YC; Cheng TH; Lee JS; Chen JH; Liao YC; Fong Y; Wu CH; Shih YW
Mol Cell Biochem; 2011 Jan; 347(1-2):103-15. PubMed ID: 20963626
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
55. A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.
Shi H; Hong A; Kong X; Koya RC; Song C; Moriceau G; Hugo W; Yu CC; Ng C; Chodon T; Scolyer RA; Kefford RF; Ribas A; Long GV; Lo RS
Cancer Discov; 2014 Jan; 4(1):69-79. PubMed ID: 24265152
[TBL] [Abstract][Full Text] [Related]
56. Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
Niessner H; Forschner A; Klumpp B; Honegger JB; Witte M; Bornemann A; Dummer R; Adam A; Bauer J; Tabatabai G; Flaherty K; Sinnberg T; Beck D; Leiter U; Mauch C; Roesch A; Weide B; Eigentler T; Schadendorf D; Garbe C; Kulms D; Quintanilla-Martinez L; Meier F
Cancer Med; 2013 Feb; 2(1):76-85. PubMed ID: 24133630
[TBL] [Abstract][Full Text] [Related]
57. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
Häggblad Sahlberg S; Mortensen AC; Haglöf J; Engskog MK; Arvidsson T; Pettersson C; Glimelius B; Stenerlöw B; Nestor M
Int J Oncol; 2017 Jan; 50(1):5-14. PubMed ID: 27878243
[TBL] [Abstract][Full Text] [Related]
58. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
59. Insulin-like growth factor 2 mRNA-binding protein 3 enhanced melanoma migration through regulation of AKT1 and RELA expression.
Sheen YS; Syu YJ; Chang YC; Hsieh PH; Liao YH; Lin MH; Chen CY; Chu CY; Chu CY
Exp Dermatol; 2024 Jan; 33(1):e15015. PubMed ID: 38284203
[TBL] [Abstract][Full Text] [Related]
60. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
